TP53 and acute myeloid leukemia: In summary, we demonstrate altered transcriptional profiles of CTLs, Tregs, and Th cells in TP53‐mutated AML, as compared to healthy controls, providing clues on mechanisms involved in the compromised immune response in this subtype of AML.